A multicenter, randomized, double-blind, placebo-controlled, Phase II clinical study of Thalidomide in the treatment of Ankylosing Spondylitis
Latest Information Update: 08 Oct 2016
At a glance
- Drugs Thalidomide (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Changzhou Pharmaceutical Factory
- 24 Feb 2016 Status changed from recruiting to completed.
- 13 Aug 2013 New trial record